Regulation of human 3α-hydroxysteroid dehydrogenase (AKR1C4) expression by the liver X receptor α

Keith R. Stayrook, Pamela M. Rogers, Rajesh S. Savkur, Yongjun Wang, Chen Su, Gabor Varga, Xin Bu, Tao Wei, Sunil Nagpal, Xiaole Shirley Liu, Thomas P. Burris

Research output: Contribution to journalArticle

16 Scopus citations


Type I human hepatic 3α-hydroxysteroid dehydrogenase (AKR1C4) plays a significant role in bile acid biosynthesis, steroid hormone metabolism, and xenobiotic metabolism. Utilization of a hidden Markov model for predictive modeling of nuclear hormone receptor response elements coupled with chromatin immunoprecipitation/microarray technology revealed a putative binding site in the AKR1C4 promoter for the nuclear hormone receptor known as liver X receptor α, (LXRα [NR1H3]), which is the physiological receptor for oxidized cholesterol metabolites. The putative LXRα response element (LXRE), identified by chromatin immunoprecipitation, was ∼1.5 kilobase pairs upstream of the transcription start site. LXRα was shown to bind specifically to this LXRE and mediate transcriptional activation of the AKR1C4 gene, leading to increased AKR1C4 protein expression. These data suggest that LXRα may modulate the bile acid biosynthetic pathway at a unique site downstream of CYP7A1 and may also modulate the metabolism of steroid hormones and certain xenobiotics.

Original languageEnglish (US)
Pages (from-to)607-612
Number of pages6
JournalMolecular pharmacology
Issue number2
StatePublished - Feb 2008

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Fingerprint Dive into the research topics of 'Regulation of human 3α-hydroxysteroid dehydrogenase (AKR1C4) expression by the liver X receptor α'. Together they form a unique fingerprint.

Cite this